Projects funded by the NCN
Gut microbiota dependent modulation of therapeutic response and side effects to irinotecan and new camptothecin analogues
2018/31/B/NZ7/02675
Keywords:
cancer micorbiome metabolome 16SrRNA-Seq mass spectrometry nmr irinotecan
Descriptors:
- NZ5_7: Human disease treatment
- NZ2_4: Metabolomics
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 15
Call: OPUS 16 - announced on 2018-09-14
Amount awarded: 1 985 598 PLN
Project start date (Y-m-d): 2019-07-26
Project end date (Y-m-d): 2024-07-25
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.